The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weaver, E. A.
Right arrow Articles by Goldman, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weaver, E. A.
Right arrow Articles by Goldman, A. S.

The Journal of Immunology, Vol 132, Issue 2 684-689, Copyright © 1984 by American Association of Immunologists


ARTICLES

Secretion of immunoglobulin A by human milk leukocytes initiated by surface membrane stimuli

EA Weaver, HE Rudloff, RM Goldblum, CP Davis and AS Goldman

Some of the requirements for release of immunoglobulin A (IgA) from human milk leukocytes during phagocytosis were investigated. The role of particle adherence in IgA release was studied by using an in vitro model of frustrated phagocytosis in which human milk leukocytes were incubated with latex particles too large to ingest. Release of IgA was significantly increased from control values within 30 min in these leukocytes. A similar increment in IgA release also occurred when human milk leukocytes were incubated with other surface membrane stimuli, e.g., NFMP and phorbol. No increase in IgA release was found, however, in cells incubated with zymosan-activated serum. In addition, the release of IgA was blocked by inhibitors of actin filaments (cytochalasin B) and microtubules (colchicine). Thus, IgA is released from human milk leukocytes by secretory mechanisms that are initiated by certain membrane stimuli, some of which are shared by peripheral blood neutrophils and monocytes. Because human milk leukocytes appear to be refractory to C5a or other activated complement components and are blocked by cytochalasin B, it appears that these unusual cells may be uniquely adapted to play a role in the immunologic protection of the neonate.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.